Evidence supporting the use of: Pomegranate
For the health condition: Contagious Diseases

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Pomegranate (Punica granatum) has a long history of use in traditional medicine, but in recent years, scientific research has begun to investigate its potential for supporting the treatment or prevention of contagious diseases, particularly due to its rich content of polyphenols, tannins, and flavonoids. Laboratory studies have demonstrated that pomegranate extracts exhibit broad-spectrum antimicrobial activity, inhibiting the growth of various bacteria, viruses, and even some fungi. Notably, pomegranate juice and its components have shown in vitro activity against influenza virus, herpes simplex virus, and certain strains of bacteria associated with respiratory and gastrointestinal infections.

However, the majority of these findings are limited to test tube and animal studies. The mechanisms attributed to pomegranate’s antimicrobial effects include disruption of microbial cell walls, inhibition of viral entry or replication, and modulation of immune responses. Despite these promising findings, clinical trials in humans are scarce, and there is insufficient evidence to recommend pomegranate as a stand-alone treatment for contagious diseases. Nonetheless, its inclusion in the diet may offer some adjunctive benefits due to its antioxidant and anti-inflammatory properties. Therefore, the use of pomegranate for supporting the management or prevention of contagious diseases is justified by preliminary scientific evidence (evidence rating: 2), but more rigorous clinical research is needed to confirm efficacy and establish guidelines for use.

More about pomegranate
More about Contagious Diseases